Participation in 'ESCMID Global 2026'

Discussions with Global Partners on the Adoption of STAgora and CURECA

On April 13, Seegene announced that it will introduce its real-time test data analysis statistical platform, STAgora™, at the ESCMID Global 2026 (European Congress of Clinical Microbiology & Infectious Diseases), which will be held in Munich, Germany from April 17 to 21 (local time). Alongside its unmanned PCR automation system, CURECA™, Seegene also plans to unveil a future diagnostic strategy that combines a data-driven real-time analysis system with test automation.


Seegene Unveils Automated, Data-Driven 'Future Diagnostic Strategy' at European Infectious Diseases Conference View original image

ESCMID Global 2026 is the largest infectious disease academic conference in Europe, where topics such as infectious disease diagnostics, antibiotic resistance, and public health response strategies are discussed. Seegene aims to set up a large exclusive booth at this event, with the goal of highlighting the future of diagnostic environments that integrate real-time data-driven interpretation with automated diagnostic infrastructure, enabled by STAgora and CURECA.


At this year's conference, Seegene will present the key message, "From Numbers to Insights." Since its initial release last year, STAgora has been upgraded and refined based on various feedback, and is being showcased as a real-time data analysis statistical platform. Designed to analyze PCR test data, STAgora enables intuitive monitoring of infectious disease trends worldwide.


Whereas conventional PCR testing was primarily focused on confirming the results of individual patients, syndromic PCR-based testing environments—which detect multiple pathogens simultaneously—allow for the comprehensive analysis of diverse infection information. Through STAgora, PCR statistical data generated from various regions can be connected in real time, enabling integrated monitoring of positive rates by pathogen, patterns of co-infection, and trends in the spread of infectious diseases.


Healthcare professionals can use STAgora to monitor infection trends in specific cities, countries, or globally in real time, and by comparing their own individual test results with regional and global statistical data, they can derive more multidimensional insights. Seegene aims to demonstrate that this structure transforms test data from simple statistical accumulation to data with practical value from a public health perspective.


Seegene will also unveil an advanced model of its unmanned PCR automation system, CURECA, at this conference. CURECA is a modular system that automates the entire PCR testing process—from sample input, pre-processing, nucleic acid extraction, amplification, to result analysis—and is expected to significantly reduce the operational burden on laboratories.



Daeho Shin, Executive Vice President and Head of Global Business at Seegene, said, "The global infectious disease diagnostics environment now requires not only the rapid efficiency of unmanned test automation systems, but also the ability to interpret results more quickly and holistically through data-driven insights. During ESCMID Global 2026, we will actively discuss the adoption of STAgora and CURECA with global partners and continue to expand our collaborations."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing